Skip to main content
Journal cover image

Long-term outcomes of mitral regurgitation by type and severity.

Publication ,  Journal Article
Samad, Z; Shaw, LK; Phelan, M; Glower, DD; Ersboll, M; Toptine, JH; Alexander, JH; Kisslo, JA; Wang, A; Mark, DB; Velazquez, EJ
Published in: Am Heart J
September 2018

BACKGROUND: We aimed to determine the association of MR severity and type with all-cause death in a large, real-world, clinical setting. METHODS: We reviewed full echocardiography studies at Duke Echocardiography Laboratory (01/01/1995-12/31/2010), classifying MR based on valve morphology, presence of coronary artery disease, and left ventricular size and function. Survival was compared among patients stratified by MR type and baseline severity. RESULTS: Of 93,007 qualifying patients, 32,137 (34.6%) had ≥mild MR. A total of 8094 (8.7%) had moderate/severe MR, which was primary myxomatous (14.1%), primary non-myxomatous (6.2%), secondary non-ischemic (17.0%), and secondary ischemic (49.4%). At 10 years, patients with primary myxomatous MR or MR due to indeterminate cause had survival rates of >60%; primary non-myxomatous, secondary ischemic, and non-ischemic MR had survival rates <50%. While mild (HR 1.06, 95% CI 1.03-1.09), moderate (HR 1.31, 95% CI 1.27-1.37), and severe (HR 1.55, 95% CI 1.46-1.65) MR were independently associated with all-cause death, the relationship of increasing MR severity with mortality varied across MR types (P ≤ .001 for interaction); the highest risk associated with worsening severity was seen in primary myxomatous MR followed by secondary ischemic MR and primary non-myxomatous MR. CONCLUSIONS: Although MR severity is independently associated with increased all-cause death risk for most forms of MR, the absolute mortality rates associated with worse MR severity are much higher for primary myxomatous, non-myxomatous, and secondary ischemic MR. The findings from this study support carefully defining MR by type and severity.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

September 2018

Volume

203

Start / End Page

39 / 48

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • United States
  • Time Factors
  • Survival Rate
  • Stroke Volume
  • Severity of Illness Index
  • Retrospective Studies
  • Prognosis
  • Mitral Valve Insufficiency
  • Mitral Valve
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Samad, Z., Shaw, L. K., Phelan, M., Glower, D. D., Ersboll, M., Toptine, J. H., … Velazquez, E. J. (2018). Long-term outcomes of mitral regurgitation by type and severity. Am Heart J, 203, 39–48. https://doi.org/10.1016/j.ahj.2018.05.001
Samad, Zainab, Linda K. Shaw, Matthew Phelan, Donald D. Glower, Mads Ersboll, John H. Toptine, John H. Alexander, et al. “Long-term outcomes of mitral regurgitation by type and severity.Am Heart J 203 (September 2018): 39–48. https://doi.org/10.1016/j.ahj.2018.05.001.
Samad Z, Shaw LK, Phelan M, Glower DD, Ersboll M, Toptine JH, et al. Long-term outcomes of mitral regurgitation by type and severity. Am Heart J. 2018 Sep;203:39–48.
Samad, Zainab, et al. “Long-term outcomes of mitral regurgitation by type and severity.Am Heart J, vol. 203, Sept. 2018, pp. 39–48. Pubmed, doi:10.1016/j.ahj.2018.05.001.
Samad Z, Shaw LK, Phelan M, Glower DD, Ersboll M, Toptine JH, Alexander JH, Kisslo JA, Wang A, Mark DB, Velazquez EJ. Long-term outcomes of mitral regurgitation by type and severity. Am Heart J. 2018 Sep;203:39–48.
Journal cover image

Published In

Am Heart J

DOI

EISSN

1097-6744

Publication Date

September 2018

Volume

203

Start / End Page

39 / 48

Location

United States

Related Subject Headings

  • Ventricular Function, Left
  • United States
  • Time Factors
  • Survival Rate
  • Stroke Volume
  • Severity of Illness Index
  • Retrospective Studies
  • Prognosis
  • Mitral Valve Insufficiency
  • Mitral Valve